Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Dapagliflozin on Exercise Capacity, Respiratory Function, Biomarkers, Sleep Apnoeas and Left Ventricular Remodelling in Heart Failure Patients

NCT05770167 is registered in ClinicalTrials.gov with Centro Cardiologico Monzino as lead sponsor.

NCT NCT05770167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05770167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Dapagliflozin on Exercise Capacity, Respiratory Function, Biomarkers, Sleep Apnoeas and Left Ventricular Remodelling in Heart Failure Patients
Lead sponsor
Centro Cardiologico Monzino
Phase
Observational
Overall status
Unknown status
Start date
May 6, 2022
Completion date
April 30, 2025
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiopulmonary exercise test, heart failure, heart failure with reduced ejection fraction, left ventricle remodeling, sleep apnea